Commodore Capital LP 13D/13G Filings for Genocea Biosciences, Inc. (GNCA)

Commodore Capital LP 13D and 13G filings for Genocea Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
4:09 pm
Purchase		 2021-12-31 13G Genocea Biosciences, Inc.
GNCA		 Commodore Capital LP 3,079,756
5.400%		 208,132increase
(+7.25%)		 Filing
2021-03-31
07:14 am
Purchase		 2021-03-22 13G Genocea Biosciences, Inc.
GNCA		 Commodore Capital LP 2,871,624
5.400%		 2,871,624increase
(New Position)		 Filing